[Current treatment of migraine].
Liaño
H
H
Servicio de Neurología, Clínica Puerta de Hierro, Universidad Autónoma, Madrid.
D000328:Adult; D002648:Child; D004087:Dihydroergotamine / Q000627:therapeutic use; D004878:Ergotamine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D008297:Male; D008784:Methysergide / Q000627:therapeutic use; D008787:Metoclopramide / Q000627:therapeutic use; D008875:Middle Aged; D008881:Migraine Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D013449:Sulfonamides / Q000627:therapeutic use; D018170:Sumatriptan; D013997:Time Factors; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D007211:Indoles; D013449:Sulfonamides; D014662:Vasoconstrictor Agents; D004087:Dihydroergotamine; D018170:Sumatriptan; D008787:Metoclopramide; D004878:Ergotamine; D008784:Methysergide
Tratamiento actual de las migrañas.